Topoisomerase II Alpha Gene Amplification and Protein Overexpression Predicting Efficacy of Epirubicin

计划入组 338 人 · 首次发布于 2005 年 9 月 13 日

Selinexor and Chemotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

计划入组 23 人 · 首次发布于 2014 年 11 月 24 日

Study to Assess TOPO2A as a Biomarker for Sensitivity to Doxorubicin/Doxil in Soft Tissue Sarcoma

计划入组 24 人 · 首次发布于 2019 年 8 月 14 日

ZEN-017

dual acting DNA topoisomerase I/II inhibitors/apoptosis inducer (cancer)

Epirubicin(Ellence, Pharmorubicin PFS)

C₂₇H₂₉NO₁₁ · Rx

Celgene International II SARL

Switzerland

Meiragtx UK II Ltd.

Belgium

Generics Bidco II, LLC

United States

Malaria Drug Pyronaridine Shows Promise as Novel Cancer Treatment

CNS Pharma's Berubicin Shows Promising Patient Retention in Recurrent GBM Trial

Race Oncology Discovers Novel Bisantrene Photoisomers, Files Patent Applications for 20-Year Protection